Nasdaq
REVB
Revelation Biosciences, Inc.
- Health Care
- Listed 2020
- 1 day
- −2.6%
- 1 month
- +13.1%
- 1 year
- −88.8%
$1.12 · Mkt cap $4.38M
At the 6 Aug 2026 close
Nasdaq
Revelation Biosciences, Inc.
$1.12 · Mkt cap $4.38M
At the 6 Aug 2026 close
Revelation Biosciences, Inc. trades under the ticker REVB on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2020. Its market capitalisation is $4.38M. The last closing price was $1.12, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −88.8%, and +13.1% over the past month. Returns are price returns and exclude dividends.
This page exists because REVB is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.